Ingredient
Cimicifuga Racemosa Root Extract
Cimicifuga Racemosa Root Extract is flagged for pregnancy, breastfeeding, trying to conceive and PCOS. The concern behind the strongest flag is hormone disruptor and fetal development.
- Black Cohosh Extract
- Actaea Racemosa Root Extract
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Not Recommended
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 4 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 1 of 5
- Higher means more likely to sting or redden
Cimicifuga Racemosa Root Extract and pregnancy
Not Recommended
- Hormone disruptor
- Fetal development
Black cohosh is a plant extract containing phytoestrogens and triterpene glycosides that can mimic estrogen in the body. While used in cosmetics for antioxidant benefits, it's the same ingredient found in oral supplements marketed for menopausal symptoms. According to ACOG and the National Center for Complementary and Integrative Health, black cohosh should be avoided during pregnancy due to its estrogenic activity and potential to stimulate uterine contractions. Several studies on oral supplementation have shown it may increase risk of preterm labor. While topical absorption is lower than oral intake, the presence of hormone-active compounds creates theoretical risks to fetal development. Most obstetricians and dermatologists recommend avoiding black cohosh in any form during pregnancy as a precautionary measure. The American Botanical Council notes insufficient safety data for pregnancy use. Given the availability of safer antioxidant alternatives, avoidance is the conservative approach.
Cimicifuga Racemosa Root Extract and breastfeeding
Not Recommended
- Passes into breast milk
- Hormone disruptor
- Infant exposure
Black cohosh contains phytoestrogens that may have hormonal effects. While specific data on topical cosmetic use during breastfeeding is limited, the ingredient's estrogenic properties raise concerns about potential transfer to breast milk and infant exposure. The National Institutes of Health and LactMed database recommend against oral black cohosh supplementation during breastfeeding due to limited safety data and potential hormonal effects on breastfed infants. Though topical application results in lower systemic absorption than oral use, the presence of hormone-active compounds warrants caution. Most lactation consultants and dermatologists advise postponing black cohosh products until after weaning. Safer antioxidant alternatives without hormonal activity are readily available and preferred during the breastfeeding period.
Cimicifuga Racemosa Root Extract and postpartum
Safe to Use
For postpartum women not breastfeeding, black cohosh extract in cosmetics poses minimal concern. The antioxidant and anti-inflammatory properties may benefit skin recovering from pregnancy-related changes. Without the consideration of infant exposure through breast milk, topical use of black cohosh at cosmetic concentrations is generally well-tolerated. Standard skin patch testing is recommended if you have sensitive skin or botanical allergies.
Cimicifuga Racemosa Root Extract and trying to conceive
Not Recommended
- Hormone disruptor
- Fertility effects
Black cohosh contains phytoestrogens that can interact with reproductive hormones. When trying to conceive, maintaining optimal hormonal balance is important, and introducing compounds with estrogenic activity may interfere with natural cycles. While topical absorption is lower than oral supplementation, the precautionary principle suggests avoiding hormone-active botanicals when actively trying to conceive. Most fertility specialists recommend eliminating unnecessary hormonal exposures during the preconception period to optimize conditions for conception and early pregnancy development.
Cimicifuga Racemosa Root Extract and PCOS
Caution Advised
- Interferes with hormones
- Affects estrogen
Black cohosh contains phytoestrogens that interact with estrogen receptors in the body. For women with PCOS, who often have hormonal imbalances involving androgens and estrogen, introducing additional estrogen-like compounds requires consideration. While topical cosmetic use results in minimal systemic absorption compared to oral supplements, the theoretical concern is that phytoestrogens could affect the delicate hormonal balance in PCOS. Some women with PCOS may benefit from gentle estrogenic effects, while others might experience interference with their hormone management. There is no specific medical guidance on topical black cohosh for PCOS. If you're managing PCOS with medications or supplements that affect hormones, discuss with your healthcare provider. Safer antioxidant options without hormonal activity are available and may be preferable.
Cimicifuga Racemosa Root Extract and general use
Safe to Use
- Common allergen
For the general public without pregnancy or hormonal concerns, black cohosh extract is primarily used in cosmetics as an antioxidant and soothing agent. It helps protect skin from environmental damage and may reduce inflammation. Topical use at cosmetic concentrations is generally well-tolerated. The main concern is potential allergic reactions in individuals sensitive to plants in the Ranunculaceae family. Patch testing is recommended for those with botanical allergies. Black cohosh has a reasonable safety profile for topical cosmetic use in non-pregnant, non-breastfeeding adults. It's commonly found in anti-aging and soothing skincare formulations without significant adverse reports.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Cimicifuga Racemosa Root Extract, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store